These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18560988)

  • 1. CCR1 antagonists.
    Cheng JF; Jack R
    Mol Divers; 2008 Feb; 12(1):17-23. PubMed ID: 18560988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR1 as a target for multiple myeloma.
    Vallet S; Anderson KC
    Expert Opin Ther Targets; 2011 Sep; 15(9):1037-47. PubMed ID: 21609295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule antagonist of C-C chemokine receptor 1 (CCR1) reduces disc inflammation in the rabbit model.
    Chou PH; Chee A; Shi P; Lin CL; Zhao Y; Zhang L; An HS
    Spine J; 2020 Dec; 20(12):2025-2036. PubMed ID: 32673730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of CCR1 antagonists for multiple myeloma.
    Karash AR; Gilchrist A
    Future Med Chem; 2011 Nov; 3(15):1889-908. PubMed ID: 22023033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-pharmacophere models for CC chemokine receptor 1 antagonists.
    Liu Y; Andre P; Wei J; Zhao K
    Med Chem; 2009 Jul; 5(4):318-24. PubMed ID: 19689388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR1 chemokine receptor antagonist.
    Saeki T; Naya A
    Curr Pharm Des; 2003; 9(15):1201-8. PubMed ID: 12769747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR1 antagonists: what have we learned from clinical trials.
    Gladue RP; Brown MF; Zwillich SH
    Curr Top Med Chem; 2010; 10(13):1268-77. PubMed ID: 20536425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel azaindazole CCR1 antagonist clinical candidates.
    Harcken C; Kuzmich D; Cook B; Mao C; Disalvo D; Razavi H; Swinamer A; Liu P; Zhang Q; Kukulka A; Skow D; Patel M; Patel M; Fletcher K; Sherry T; Joseph D; Smith D; Canfield M; Souza D; Bogdanffy M; Berg K; Brown M
    Bioorg Med Chem Lett; 2019 Feb; 29(3):441-448. PubMed ID: 30595446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338.
    Carter PH; Hynes J
    Expert Opin Ther Pat; 2010 Nov; 20(11):1609-18. PubMed ID: 20858032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR1 and CCR2 antagonists.
    Zimmermann HW; Sterzer V; Sahin H
    Curr Top Med Chem; 2014; 14(13):1539-52. PubMed ID: 25159163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Role of CCR1 in the Central Nervous System.
    Tian Q; Yan Z; Guo Y; Chen Z; Li M
    Neuroimmunomodulation; 2024; 31(1):173-182. PubMed ID: 39116843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and optimization of pyrazole amides as antagonists of CCR1.
    Harcken C; Sarko C; Mao C; Lord J; Raudenbush B; Razavi H; Liu P; Swinamer A; Disalvo D; Lee T; Lin S; Kukulka A; Grbic H; Patel M; Patel M; Fletcher K; Joseph D; White D; Amodeo L; Berg K; Brown M; Thomson DS
    Bioorg Med Chem Lett; 2019 Feb; 29(3):435-440. PubMed ID: 30455146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists.
    Pennell AM; Aggen JB; Sen S; Chen W; Xu Y; Sullivan E; Li L; Greenman K; Charvat T; Hansen D; Dairaghi DJ; Wright JJ; Zhang P
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1228-31. PubMed ID: 23374868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and structure activity relationships of spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Ivanova S; Bergare J; Mensonides-Harsema M; Cooper ME
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3500-4. PubMed ID: 23659855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor antagonists: Part 1.
    Pease JE; Horuk R
    Expert Opin Ther Pat; 2009 Jan; 19(1):39-58. PubMed ID: 19441897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pyrrolidine ureas as C-C chemokine receptor 1 (CCR1) antagonists.
    Merritt JR; Liu J; Quadros E; Morris ML; Liu R; Zhang R; Jacob B; Postelnek J; Hicks CM; Chen W; Kimble EF; Rogers WL; O'Brien L; White N; Desai H; Bansal S; King G; Ohlmeyer MJ; Appell KC; Webb ML
    J Med Chem; 2009 Mar; 52(5):1295-301. PubMed ID: 19183043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653.
    Norman P
    Expert Opin Ther Pat; 2009 Nov; 19(11):1629-33. PubMed ID: 19586423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and structure-activity relationships of zwitterionic spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Ivanova S; Timén ÅS; Bergare J; Mussie T; Bergström L
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4026-30. PubMed ID: 23769642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR1 antagonists for the treatment of autoimmune diseases.
    Gladue RP; Zwillich SH; Clucas AT; Brown MF
    Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure activity relationships of fused bicyclic and urea derivatives of spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Mensonides-Harsema M; Cooper ME; Eriksson T; Ivanova S; Bergström L
    Bioorg Med Chem Lett; 2014 Jan; 24(1):108-12. PubMed ID: 24332486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.